Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study

• मुख्य लेखकों: Veera C. S. R. Chittepu (लेखक), Poonam Kalhotra (लेखक), Tzayhri Osorio-Gallardo (लेखक), Tzayhri Gallardo-Velázquez (लेखक), Guillermo Osorio-Revilla (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2019-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

A drug repurposing strategy could be a potential approach to overcoming the economic costs for diabetes mellitus (DM) treatment incurred by most countries. DM has emerged as a global epidemic, and an increase in the outbreak has led developing countries like Mexico, India, and China to recommend a p...